Étude portant sur le V937 en association avec le pembrolizumab chez des participants atteints de tumeurs solides avancées ou métastatiques
The purpose of this study is to evaluate the safety, tolerability, and efficacy in participants with advanced/metastatic or recurrent malignancies who receive V937 in Combination with Pembrolizumab (MK-3475). The primary objective